BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30303134)

  • 1. C-cell hyperplasia in sporadic and familial medullary thyroid carcinoma.
    Yadav M; Agrawal V; Pani KC; Verma R; Jaiswal S; Mishra A; Pandey R
    Indian J Pathol Microbiol; 2018; 61(4):485-488. PubMed ID: 30303134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologic versus neoplastic C-cell hyperplasia of the thyroid: separation of distinct histologic and biologic entities.
    Perry A; Molberg K; Albores-Saavedra J
    Cancer; 1996 Feb; 77(4):750-6. PubMed ID: 8616768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemistry of medullary thyroid carcinoma and C-cell hyperplasia by an affinity-purified anti-human calcitonin antiserum.
    Hayashida CY; Alves VA; Kanamura CT; Ezabella MC; Abelin NM; Nicolau W; Bisi H; Toledo SP
    Cancer; 1993 Aug; 72(4):1356-63. PubMed ID: 8339225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thyroid C cells and their pathology: Part 1: normal C cells, - C cell hyperplasia, - precursor of familial medullary thyroid carcinoma].
    Ting S; Synoracki S; Schmid KW
    Pathologe; 2015 May; 36(3):246-53. PubMed ID: 25898937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-cell hyperplasia and medullary thyroid carcinoma: clinicopathological and genetic correlations in 66 consecutive patients.
    Guyétant S; Josselin N; Savagner F; Rohmer V; Michalak S; Saint-André JP
    Mod Pathol; 2003 Aug; 16(8):756-63. PubMed ID: 12920219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary hereditary medullary thyroid carcinoma--C-cell morphology and correlation with preoperative calcitonin levels.
    Hinze R; Holzhausen HJ; Gimm O; Dralle H; Rath FW
    Virchows Arch; 1998 Sep; 433(3):203-8. PubMed ID: 9769122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polysialic acid of the neural cell adhesion molecule in the human thyroid: a marker for medullary thyroid carcinoma and primary C-cell hyperplasia. An immunohistochemical study on 79 thyroid lesions.
    Komminoth P; Roth J; Saremaslani P; Matias-Guiu X; Wolfe HJ; Heitz PU
    Am J Surg Pathol; 1994 Apr; 18(4):399-411. PubMed ID: 8141431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
    Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests.
    Scheuba C; Kaserer K; Weinhäusl A; Pandev R; Kaider A; Passler C; Prager G; Vierhapper H; Haas OA; Niederle B
    Surgery; 1999 Dec; 126(6):1089-95; discussion 1096. PubMed ID: 10598192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thyroid C cells and their pathology: Part 2: Medullary thyroid carcinoma].
    Synoracki S; Schmid ST; Ting S; Schmid KW
    Pathologe; 2015 May; 36(3):254-60. PubMed ID: 25917773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expression.
    Smith J; Read ML; Hoffman J; Brown R; Bradshaw B; Campbell C; Cole T; Navas JD; Eatock F; Gundara JS; Lian E; Mcmullan D; Morgan NV; Mulligan L; Morrison PJ; Robledo M; Simpson MA; Smith VE; Stewart S; Trembath RC; Sidhu S; Togneri FS; Wake NC; Wallis Y; Watkinson JC; Maher ER; McCabe CJ; Woodward ER
    Hum Mol Genet; 2016 May; 25(9):1836-45. PubMed ID: 26945007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
    Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
    World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients.
    Kaserer K; Scheuba C; Neuhold N; Weinhäusel A; Haas OA; Vierhapper H; Niederle B
    Am J Surg Pathol; 2001 Oct; 25(10):1245-51. PubMed ID: 11688458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ["Physiological" and "neoplastic" C-cell hyperplasia of the thyroid. Morphologically and biologically distinct entities?].
    Hinze R; Gimm O; Brauckhoff M; Schneyer U; Dralle H; Holzhausen HJ
    Pathologe; 2001 Jul; 22(4):259-65. PubMed ID: 11490939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different outcomes in sporadic versus familial medullary thyroid cancer.
    Saltiki K; Simeakis G; Anagnostou E; Zapanti E; Anastasiou E; Alevizaki M
    Head Neck; 2019 Jan; 41(1):154-161. PubMed ID: 30548085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presurgical assessment of the tumor burden of familial medullary thyroid carcinoma by calcitonin testing.
    Pomares FJ; Rodríguez JM; Nicolás F; Sola J; Canteras M; Balsalobre M; Pascual M; Parrilla P; Tébar FJ
    J Am Coll Surg; 2002 Nov; 195(5):630-4. PubMed ID: 12437249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-cell hyperplasia and medullary thyroid carcinoma in the rat. An immunohistochemical and ultrastructural analysis.
    DeLellis RA; Nunnemacher G; Bitman WR; Gagel RF; Tashjian AH; Blount M; Wolfe HJ
    Lab Invest; 1979 Feb; 40(2):140-54. PubMed ID: 431034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinico-pathologic and dynamic prognostic factors in sporadic and familial medullary thyroid carcinoma: an Israeli multi-center study.
    Twito O; Grozinsky-Glasberg S; Levy S; Bachar G; Gross DJ; Benbassat C; Rozental A; Hirsch D
    Eur J Endocrinol; 2019 Jul; 181(1):13-21. PubMed ID: 31048559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current understanding and management of medullary thyroid cancer.
    Roy M; Chen H; Sippel RS
    Oncologist; 2013; 18(10):1093-100. PubMed ID: 24037980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medullary Thyroid Carcinoma: Survival Analysis and Evaluation of Mutation-Specific Immunohistochemistry in Detection of Sporadic Disease.
    Jayakody S; Reagh J; Bullock M; Aniss A; Clifton-Bligh R; Learoyd D; Robinson B; Delbridge L; Sidhu S; Gill AJ; Sywak M
    World J Surg; 2018 May; 42(5):1432-1439. PubMed ID: 29484475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.